comparemela.com

Latest Breaking News On - Luiz carlos dias - Page 1 : comparemela.com

Brazilian bishop resigns at 62; accused of sexually harassing priests, seminarians | News Headlines

Pope Francis has accepted the resignation of Bishop Valdir Mamede of Catanduva, Brazil.

Distrito federalPope francisMoacir silvaBishop luiz carlos diasBishop mamedeBishop valdir mamedeDiocese of catanduvaCatholic worldArchbishop moacir silvaLuiz carlos diasFather mamedePope benedict

Matching Sinopharm, fellow China biotech Sinovac sees 78% COVID-19 vaccine efficacy

A little over a week after Sinopharm nabbed the world’s first full approval from Chinese regulators on a 79% efficacy showing for its COVID-19 vax, fellow Chinese native Sinovac, using similar tech, has shown pretty much the same numbers.

Luiz carlos diasJair bolsonaroUniversity of oxfordUniversity of campinasClinical trials summitPremier educational event focusedDecentralized clinicalWall streetLancet infectious diseasesSinovac biotechSino pharmCovid 19Corona virusலூயிஸ் கார்லோஸ் டயஸ்ஜெயர் போல்சனாரோபல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட்

Chinese vaccine test results delayed

© Getty Images Chinese pharmaceutical company Sinovac will reportedly delay releasing the results from its various COVID-19 vaccine trials until January. Sources told The Wall Street Journal that Sinovac’s vaccine, CoronaVac, had recently reached phase three trials in Brazil, where it had been shown to be more than 50 percent effective at preventing the coronavirus. However, the Journal reported this week that Sinovac asked the Butantan Institute, the Brazilian research center that has been testing the vaccine, to delay releasing results for another 15 days as it compiles data from other trials in Indonesia and Turkey. ADVERTISEMENT “There can’t be three efficacy results for the same vaccine,” said Dimas Covas, Butantan’s director, according to the Journal. According to Covas, the delay has nothing to do with the efficacy of the vaccine, which is expected to be among the first authorized for use in Brazil.

Dimas covasLuiz carlos diasButantan instituteUniversity of campinasWall street journalCarlos diasடைமாஸ் கோவாஸ்லூயிஸ் கார்லோஸ் டயஸ்புத்தாண்தான் நிறுவனம்பல்கலைக்கழகம் ஆஃப் காம்பினாக்கள்சுவர் தெரு இதழ்கார்லோஸ் டயஸ்

China s Sinovac Delays Covid-19 Vaccine Trial Results

Updated Dec. 23, 2020 5:02 pm ET SÃO PAULOâChinese firm Sinovac Biotech Ltd. has delayed the announcement of results from late-stage trials of its Covid-19 vaccine to January as it consolidates data from Brazil with test results from Indonesia and Turkey. Brazil, which is the first country to complete Phase 3 trials of CoronaVac, had been expected to announce the vaccineâs efficacy rate on Wednesday. However, Brazilâs Butantan Institute, the research center backed by SÃ£o Pauloâs state government that has been testing CoronaVac, said Sinovac asked for 15 more days to analyze the data together with results from other trials of the vaccine, which is also being tested in Indonesia and Turkey.

Dimas covasLuiz carlos diasBrazil butantan instituteSinovac biotech ltdUniversity of campinasSinovac biotechButantan instituteடைமாஸ் கோவாஸ்லூயிஸ் கார்லோஸ் டயஸ்பிரேசில் புத்தாண்தான் நிறுவனம்பல்கலைக்கழகம் ஆஃப் காம்பினாக்கள்புத்தாண்தான் நிறுவனம்

vimarsana © 2020. All Rights Reserved.